COVID-19: ICMR to set up registry of hospitalised patients
The registry will help improve treatment outcomes, analyse trends in the progression of the pandemic and calibrate response, officials said.
The ICMR in collaboration with the Health Ministry and the AIIMS is planning to set up the National Clinical Registry which will help researchers and policy makers understand effectiveness of investigational therapies, adverse effects taking place and generate evidence for improving the treatment of COVID-19 patients.
The registry of hospitalised COVID-19 patients across the country will collect real time data to help improve treatment outcomes, analyse trends in the progression of the pandemic and calibrate response, officials said.
"The aim is to collect data of the hospitalised COVID-19 patients such as clinical and laboratory features, their demographics, comorbidities, treatment outcomes, complications in all age groups among others," officials said.
"A systematically collected, comprehensive database covering different regions of the country will enable both researchers and policy makers to generate pertinent hypotheses, to inform crucial understanding of COVID 19, to detect trends in the progression of the pandemic and to accordingly calibrate response to the pandemic," an official said.
Fifteen institutions of national repute including the Post Graduate Institute of Medical Education & Research (PGIMER) in Chandigarh, AIIMS Delhi, AIIMS Jodhpur, National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru and Armed Force Medical College in Pune will connect with the hospitals and medical colleges to get them on board.
These institutions will serve as the registry sites and mentor around 100 COVID-19 hospitals. The hospitals would be called satellite centres from where the data would be collected as part of the exercise.
The proposal has been sent for approval to the Central Ethics Committee on Human Research (CECHR) of the ICMR. "The data will help improve the clinical management protocols as the repository would help us know which drug is working better in which age group, effectiveness of investigational therapies and adverse effects taking place. The idea is to generate evidence for improving the treatment of COVID-19 patients," another official said.
According to the ICMR, a cumulative total of 1,98,21,831 samples have been tested up to August 1 with 463,172 samples being tested on Saturday. India's COVID-19 tally crossed the 17-lakh mark on Sunday, just two days after it went past 16 lakh. With 54,735 cases being reported in a day, the total coronavirus cases surged to 17,50,723.While the death toll climbed to 37,364 with 853 people succumbing to the disease in a day, the data revealed that the fatality rate has further dropped to 2.13 per cent. The health ministry stressed that more than 70 per cent of the deaths occurred due to comorbidities.
The recoveries have mounted to 11,45,629, while there are 5,67,730 active cases of coronavirus infection in the country presently.
(With PTI inputs)